Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BGNE | SRPT | INCY | ||
| Company | Beigene Ltd ADR | Sarepta Therapeutics | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 149.00 | 152.57 | 57.48 | ||
| High | 149.00 | 152.58 | 57.58 | ||
| Low | 145.53 | 150.98 | 56.75 | ||
| Last | 147.04 | 151.73 | 57.33 | ||
| Change | -0.94 | -1.38 | -0.33 | ||
| % Change | -0.64% | -0.90% | -0.57% | ||
| Volume | 88,432 | 961,918 | 2,092,512 | ||
| 20-Day Average Volume | 188,787 | 2,293,236 | 5,307,786 | ||
| Previous Close | 147.98 | 153.11 | 57.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 154.00 | 139.08 | 60.82 | ||
| 20-Day Raw Stochastic | 20.57% | 62.58% | 7.68% | ||
| 20-Day Relative Strength | 44.31% | 60.87% | 43.44% | ||
| Weighted Alpha | -24.02 | +44.30 | -6.77 | ||
| Today's Opinion | 88% Sell | 100% Buy | 40% Sell | ||
| Previous Opinion | 88% Sell | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Sell | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.00% since 06/27/24 | -3.94% since 06/27/24 | -6.55% since 06/27/24 | ||
| Low | 141.84 on 06/28/24 | 150.98 on 07/05/24 | 56.75 on 07/05/24 | ||
| High | 149.00 on 07/05/24 | 162.95 on 07/01/24 | 61.99 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | -7.54% since 06/05/24 | +26.66% since 06/05/24 | -2.88% since 06/05/24 | ||
| Low | 141.31 on 06/27/24 | 115.74 on 06/20/24 | 56.75 on 07/05/24 | ||
| High | 169.17 on 06/12/24 | 173.25 on 06/21/24 | 64.30 on 06/18/24 | ||
| 3-Month | |||||
| %Chg | -1.99% since 04/05/24 | +20.34% since 04/05/24 | +3.78% since 04/05/24 | ||
| Low | 126.97 on 04/19/24 | 109.91 on 05/28/24 | 50.35 on 04/30/24 | ||
| High | 176.00 on 05/17/24 | 173.25 on 06/21/24 | 64.30 on 06/18/24 | ||
| 6-Month | |||||
| %Chg | -11.09% since 01/05/24 | +55.88% since 01/05/24 | -12.15% since 01/05/24 | ||
| Low | 126.97 on 04/19/24 | 94.75 on 01/08/24 | 50.35 on 04/30/24 | ||
| High | 184.80 on 03/13/24 | 173.25 on 06/21/24 | 66.17 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,280,364 | 14,472,570 | 12,947,034 | ||
| Shares Outstanding, K | 96,502 | 94,524 | 224,541 | ||
| Annual Sales | 2,458,780,000 | 1,243,340,000 | 3,695,650,000 | ||
| Annual Net Income | -881,710,000 | -535,980,000 | 597,600,000 | ||
| Last Quarter Sales | 751,650,000 | 413,460,000 | 880,890,000 | ||
| Last Quarter Net Income | -251,150,000 | 36,120,000 | 169,550,000 | ||
| 60-Month Beta | 0.59 | 0.89 | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.41 on 05/08/24 | 0.73 on 05/01/24 | 0.64 on 04/30/24 | ||
| Latest Earnings Date | 08/07/24 | 08/07/24 | 08/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 1,285.00 | 20.49 | ||